MedWatch

Exiqon launches yet another product

The product portfolio in the Danish company Exiqon is now expanded with new panels for preclinical toxicological research.

Foto: Exiqon / PR

The listed Danish gene analysis firm, Exiqon, has finished development of yet another analysis instrument, which is now set to be launched on the market – third generation microRNA qPCR panels for preclinical toxicological research to be exact.

“The interest in using microRNA as a biomarker for measuring toxicity and tissue damage has really picked up in the last year or so,” Henrik Pfundheller, Senior VP, Sales & Marketing, says in a press release.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier